Christopher Francklyn

Christopher Francklyn

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
CFChristopher Francklyn
Christopher Francklyn
PMPatrick Mullen
Patrick Mullen
Aminoacyl-tRNA synthetases (ARSs) are universal enzymes that catalyze the attachment of amino acids to the 3′ ends of their cognate tRNAs. The resulting aminoacylated tRNAs are escorted to the ribosome where they enter protein synthesis. By specifically matching amino acids to defined anticodon sequences in tRNAs, ARSs are essential to the physical interpretation of the genetic code. In addition to their canonical role in protein synthesis, ARSs are also involved in RNA splicing, transcriptional regulation, translation, and other aspects of cellular homeostasis. Likewise, aminoacylated tRNAs serve as amino acid donors for biosynthetic processes distinct from protein synthesis, including lipid modification and antibiotic biosynthesis. Thanks to the wealth of details on ARS structures and functions and the growing appreciation of their additional roles regulating cellular homeostasis, opportunities for the development of clinically useful ARS inhibitors are emerging to manage microbial and parasite infections. Exploitation of these opportunities has been stimulated by the discovery of new inhibitor frameworks, the use of semi-synthetic approaches combining chemistry and genome engineering, and more powerful techniques for identifying leads from the screening of large chemical libraries. Here, we review the inhibition of ARSs by small molecules, including the various families of natural products, as well as inhibitors developed by either rational design or high-throughput screening as antibiotics and anti-parasitic therapeutics.

1 February 2008 in Methods
Verified
Journal Article
Closed access
CFChristopher Francklyn
Christopher Francklyn
EFEric A. First
Eric A. First
JPJohn J. Perona
John J. Perona
YHYa-Ming Hou
Ya-Ming Hou

31 March 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
PFPengfei Fang
Pengfei Fang
XYXue Yu
Xue Yu
SJSeung Jae Jeong
Seung Jae Jeong
AMAdam Mirando
Adam Mirando
KCKaige Chen
Kaige Chen
MGMin Guo
Min Guo
The polyketide natural product borrelidin displays antibacterial, antifungal, antimalarial, anticancer, insecticidal and herbicidal activities through the selective inhibition of threonyl-tRNA synthetase (ThrRS). How borrelidin simultaneously attenuates bacterial growth and suppresses a variety of infections in plants and animals is not known. Here we show, using X-ray crystal structures and functional analyses, that a single molecule of borrelidin simultaneously occupies four distinct subsites within the catalytic domain of bacterial and human ThrRSs. These include the three substrate-binding sites for amino acid, ATP and tRNA associated with aminoacylation, and a fourth ‘orthogonal’ subsite created as a consequence of binding. Thus, borrelidin competes with all three aminoacylation substrates, providing a potent and redundant mechanism to inhibit ThrRS during protein synthesis. These results highlight a surprising natural design to achieve the quadrivalent inhibition of translation through a highly conserved family of enzymes.

1 February 2007 in Molecular Cell
Verified
Journal Article
Closed access
EGEthan C. Guth
Ethan C. Guth
CFChristopher Francklyn
Christopher Francklyn

17 November 2009 in FEBS Letters
Verified
Journal Article
Open access
PDF file
CFChristopher Francklyn
Christopher Francklyn
AMAnand Minajigi
Anand Minajigi
During protein synthesis, tRNA serves as the intermediary between cognate amino acids and their corresponding RNA trinucleotide codons. Aminoacyl‐tRNA is also a biosynthetic precursor and amino acid donor for other macromolecules. AA‐tRNAs allow transformations of acidic amino acids into their amide‐containing counterparts, and seryl‐tRNASer donates serine for antibiotic synthesis. Aminoacyl‐tRNA is also used to cross‐link peptidoglycan, to lysinylate the lipid bilayer, and to allow proteolytic turnover via the N‐end rule. These alternative functions may signal the use of RNA in early evolution as both a biological scaffold and a catalyst to achieve a wide variety of chemical transformations.

17 January 2011 in Biochemistry
Verified
Journal Article
Closed access
ZPZvi Pasman
Zvi Pasman
SRSusan Robey-Bond
Susan Robey-Bond
AMAdam C. Mirando
Adam C. Mirando
GSGregory J. Smith
Gregory J. Smith
ALAstrid Lague
Astrid Lague
CFChristopher Francklyn
Christopher Francklyn